Insmed (INSM)
(Real Time Quote from BATS)
$75.18 USD
-1.15 (-1.51%)
Updated Aug 30, 2024 12:24 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Insmed, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 780 | 1,148 | 717 | 533 | 487 |
Receivables | 41 | 30 | 24 | 17 | 19 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 83 | 70 | 67 | 50 | 28 |
Other Current Assets | 24 | 25 | 29 | 24 | 20 |
Total Current Assets | 929 | 1,273 | 837 | 623 | 555 |
Net Property & Equipment | 65 | 56 | 53 | 54 | 60 |
Investments & Advances | 0 | 0 | 50 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 200 | 205 | 210 | 49 | 54 |
Deposits & Other Assets | 97 | 76 | 51 | 27 | 20 |
Total Assets | 1,330 | 1,656 | 1,244 | 796 | 742 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 215 | 182 | 36 | 43 | 13 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 3 | 1 | 1 | 1 | 1 |
Accrued Expenses | 0 | 0 | 89 | 63 | 60 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 226 | 190 | 135 | 119 | 85 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,155 | 1,125 | 567 | 356 | 336 |
Non-Current Capital Leases | 27 | 30 | 14 | 15 | 20 |
Other Non-Current Liabilities | 243 | 209 | 96 | 9 | 11 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,662 | 1,568 | 833 | 520 | 481 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 3,113 | 2,782 | 2,674 | 2,105 | 1,797 |
Retained Earnings | -3,446 | -2,697 | -2,265 | -1,831 | -1,537 |
Other Equity | -1 | 1 | 1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -332 | 88 | 410 | 276 | 262 |
Total Liabilities & Shareholder's Equity | 1,330 | 1,656 | 1,244 | 796 | 742 |
Total Common Equity | -332 | 88 | 410 | 276 | 262 |
Shares Outstanding | 143.00 | 135.40 | 118.30 | 101.80 | 89.30 |
Book Value Per Share | -2.32 | 0.65 | 3.47 | 2.71 | 2.93 |
Fiscal Year End for Insmed, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,247 | 596 | 780 | 786 | 918 |
Receivables | 40 | 37 | 41 | 36 | 31 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 90 | 83 | 83 | 78 | 77 |
Other Current Assets | 41 | 43 | 24 | 27 | 26 |
Total Current Assets | 1,418 | 759 | 929 | 927 | 1,052 |
Net Property & Equipment | 73 | 69 | 65 | 65 | 62 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 197 | 199 | 200 | 201 | 202 |
Deposits & Other Assets | 86 | 96 | 97 | 92 | 83 |
Total Assets | 1,810 | 1,159 | 1,330 | 1,325 | 1,439 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 291 | 189 | 215 | 188 | 198 |
Current Portion Long-Term Debt | 224 | 224 | 0 | 0 | 0 |
Current Portion Capital Leases | 3 | 3 | 3 | 3 | 2 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 524 | 421 | 226 | 197 | 204 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 947 | 939 | 1,155 | 1,148 | 1,140 |
Non-Current Capital Leases | 26 | 26 | 27 | 28 | 28 |
Other Non-Current Liabilities | 263 | 243 | 229 | 210 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,771 | 1,624 | 1,662 | 1,614 | 1,595 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 1 | 1 | 1 | 1 |
Capital Surplus | 3,944 | 3,139 | 3,113 | 2,971 | 2,945 |
Retained Earnings | -3,904 | -3,603 | -3,446 | -3,260 | -3,101 |
Other Equity | -3 | -2 | -1 | -2 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 39 | -465 | -332 | -289 | -156 |
Total Liabilities & Shareholder's Equity | 1,810 | 1,159 | 1,330 | 1,325 | 1,439 |
Total Common Equity | 39 | -465 | -332 | -289 | -156 |
Shares Outstanding | 148.60 | 148.50 | 143.00 | 143.00 | 136.40 |
Book Value Per Share | 0.26 | -3.13 | -2.32 | -2.02 | -1.14 |